Publications
30
Citations
335
Est. group size
—
Recurring co-author estimate
Active years
25
Publishing since 2001
Typically publishes in teams of ~10 · 0% small-team papers (≤3 authors) · across 5 venues
- Interim Results from the Phase 1B and Phase 2 TORREY Open-label Extension Study of Seralutinib in Pulmonary Arterial Hypertension (PAH)
Pneumologie · 2025
- 10-year Data on Oral Selexipag: Long-Term Survival, Safety, and Dosing Insights in Pulmonary Arterial Hypertension (PAH) from the GRIPHON Study and Its Open-Label Extension (OLE)
The Journal of Heart and Lung Transplantation · 2025
- Burden and Unmet Needs in Women with Pulmonary Arterial Hypertension: Multinational Physician Qualitative Study
2024
- UNISUS study design: a phase 3 superiority study comparing the efficacy, safety, and tolerability of macitentan 75 mg vs macitentan 10 mg in patients with pulmonary arterial hypertension (PAH)
European Heart Journal · 2022
- Epidemiology and Treatment Patterns of Pulmonary Arterial Hypertension (PAH) Patients Across US Regions Using Real-World Data from OPUS/OrPHeUS
2021
- PULSAR Study Open-Label Extension: Interim Results from a Phase 2 Study of the Efficacy and Safety of Sotatercept When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
2021
- Characteristics and clinical course of the first 500 patients (pts) from SPHERE (SelexiPag: tHe usErs dRug rEgistry) receiving selexipag in real-world clinical practice
European Heart Journal · 2020
- PCV3 Hospitalization Rates and Association with Survival Risk at Baseline in Patients with Pulmonary Artery Hypertension (PAH) Receiving Selexipag in Real-World (RW) Clinical Practice
Value in Health · 2020
- Study Design of the Phase 3 ADVANCE Program Evaluating Time-to-Clinical Events and Exercise Capacity in Patients with Pulmonary Arterial Hypertension Treated with Ralinepag
2019
- 4973Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities
European Heart Journal · 2019
- Cibler la voie de la prostacycline dans le traitement des HTAP associées aux connectivites : expérience de Griphon – étude contrôlée, randomisée avec le selexipag
La Revue de Médecine Interne · 2016
- European Heart Journal×4
- The Journal of Heart and Lung Transplantation×3
- Pneumologie×2
- Value in Health×1
- La Revue de Médecine Interne×1
- Vallerie V. McLaughlin
Medicine · University of Michigan
- Rachel D’Amico
Medicine · The Ohio State University
- Raymond L. Benza
Medicine · The Ohio State University
- Verónica Franco
Medicine · The Ohio State University
- Amanda Fisher
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile